These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 34452323)

  • 1. Human Coronaviruses: Counteracting the Damage by Storm.
    Schoeman D; Fielding BC
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
    Wielgat P; Rogowski K; Godlewska K; Car H
    Cells; 2020 Aug; 9(9):. PubMed ID: 32854433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of the Clinical, Viral, Pathologic, and Immunologic Features of Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), and Coronavirus 2019 (COVID-19) Diseases.
    Barth RF; Buja LM; Barth AL; Carpenter DE; Parwani AV
    Arch Pathol Lab Med; 2021 Oct; 145(10):1194-1211. PubMed ID: 34232978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
    Wang Y; Grunewald M; Perlman S
    Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interspecies Jumping of Bat Coronaviruses.
    Wong ACP; Lau SKP; Woo PCY
    Viruses; 2021 Oct; 13(11):. PubMed ID: 34834994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.
    Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY
    Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2.
    Yao Z; Zheng Z; Wu K; Junhua Z
    Aging (Albany NY); 2020 May; 12(9):7639-7651. PubMed ID: 32364527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.
    da Costa VG; Moreli ML; Saivish MV
    Arch Virol; 2020 Jul; 165(7):1517-1526. PubMed ID: 32322993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS and MERS: recent insights into emerging coronaviruses.
    de Wit E; van Doremalen N; Falzarano D; Munster VJ
    Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction - Emerging Pathogens and the COVID-19 Pandemic.
    McFee RB
    Dis Mon; 2020 Sep; 66(9):101065. PubMed ID: 32758362
    [No Abstract]   [Full Text] [Related]  

  • 14. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview.
    Rabaan AA; Al-Ahmed SH; Haque S; Sah R; Tiwari R; Malik YS; Dhama K; Yatoo MI; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Infez Med; 2020 Ahead Of Print Jun 1; 28(2):174-184. PubMed ID: 32275259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned.
    Ryabkova VA; Churilov LP; Shoenfeld Y
    Clin Immunol; 2021 Feb; 223():108652. PubMed ID: 33333256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
    J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.
    Asrani P; Hasan GM; Sohal SS; Hassan MI
    OMICS; 2020 Nov; 24(11):634-644. PubMed ID: 32940573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models for SARS and MERS coronaviruses.
    Gretebeck LM; Subbarao K
    Curr Opin Virol; 2015 Aug; 13():123-9. PubMed ID: 26184451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    Yashavantha Rao HC; Jayabaskaran C
    J Med Virol; 2020 Jul; 92(7):786-790. PubMed ID: 32320066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.